Exelixis Inc (EXEL)
37.01
-0.70
(-1.86%)
USD |
NASDAQ |
Mar 26, 16:00
37.01
0.00 (0.00%)
After-Hours: 18:02
Exelixis Market Cap: 10.36B for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics Inc | 7.862B |
| Biomarin Pharmaceutical Inc | 13.64B |
| Incyte Corp | 11.85B |
| Catalyst Pharmaceuticals Inc | 3.056B |
| Blueprint Medicines Corp | 5.796B |
Market Cap Related Metrics
| PE Ratio | 20.91 |
| PS Ratio | 5.054 |
| PEG Ratio | 0.1193 |
| Price to Book Value | 4.616 |
| Price to Free Cash Flow | 17.29 |
| Price | 37.01 |
| Earnings Yield | 4.78% |
| PEGY Ratio | 0.1193 |
| Operating PE Ratio | 15.89 |
| Normalized PE Ratio | 18.61 |